medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2017; 16 (4)


Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma

Chinchilla-López P, Aguilar-Olivos NE, García-Gómez J, Hernández-Alejandro KK, Chablé-Montero F, Motola-Kuba D, Patel T, Méndez-Sánchez N

Idioma: Ingles.
Referencias bibliográficas: 22
Paginas: 565-568
Archivo PDF: 123.92 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008; 1: 84-96.

  2. Khan SA, Thomas HC, Davidson BR, Taylor SD. Cholangiocarcinoma. Lancet 2005; 9493: 1303-14.

  3. Morise Z, Sugioka A, Tokoro T, Tanahashi Y, Okabe Y, Kagawa T, Takeura C. Surgery and chemotherapy for intrahepatic cholangiocarcinoma. World J Hepatol 2010; 2: 58-64.

  4. Doherty B, Nambudiri VE, Palmer WC. Update on the Diagnosis and Treatment of Cholangiocarcinoma. Curr Gastroenterol Rep 2017; 1: 2.

  5. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002; 2: 10.

  6. Khan SA, Taylor SD, Toledano MB, Beck A, Elliot P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002; 6: 806-13.

  7. McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006; 6: 1198-203.

  8. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004; 3: 472-7.

  9. Shaib YH, Davila JA, Henderson L, McGlynn KA, El-Serag HB. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the United States: a population- based study. J Clin Gastroenterol 2007; 10: 911-7.

  10. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population- based study of U.S. veterans. Hepatology 2009; 1: 116-23.

  11. Ustundag Y, Bayraktar Y. Cholangiocarcinoma: a compact review of the literature. World J Gastroenterol 2008; 42: 6458-66.

  12. Ronnekleiv SM, Pawlik TM. Stating of intrahepatic cholangiocarcinoma. Hepatobil Surg Nutr 2017; 1: 35-43.

  13. Sirica AE, Dumur CI, Campbell DJ, Almenara JA, Ogunwobi OO, Dewitt JL.Intrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms. Clinical Gastroenteroly and Hepatology: the official clinical practice Journal of the American Gastroenterology Association 2009; 11: S68-78.

  14. Khan SA, Emadossadaty S, Ladep NG, Thomas HC, Elliott P, Taylor-Robinson SD, Toledano MB. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol 2012; 4: 848-54.

  15. McLean L, Pate T. Racial and ethnic variation in the epidemiology of intrahepatic cholangiocarcinoma in the United States. Liver International: official journal of the International Association for the study of the liver 2006; 9: 1047-53.

  16. Razumilava N, Gores G. Cholangiocarcinoma. Lancet 2014; 9935: 2168-79.

  17. Shaib Y, El-Serag HB. The Epidemiology of cholangiocarcinoma. Seminars in Liver Disease 2004; 2: 115-25.

  18. Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014; 6: 1268-89.

  19. Yuan L, Luo X, Lu X, Huang B, Cai Q. Liver resection for intrahepatic cholangiocarcinoma in AJCC stage: An evaluation of the survival benefit and prognostic accuracy of current AJCC stating sustem on N and M classification. Oncology Reports 2016; 5: 2663-72.

  20. Benito del Valle M, Muller T, Bjornsson E, Otten M, Volkmann M, Guckelberger O, Wiedenmann B, et al. The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis. Dig Liver Dis: official journal of the Italian Society of Gastroenteroly and de Italian Association for the study of the Liver 2014; 10: 903-8.

  21. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population- based case-control study. Clin Gastroenterol Hepatol: the official clinical practice journal of the American Gastroenterological Association 2007; 10: 1221-8.

  22. Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Wiangnon S, et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Science 2010; 3: 579-85.




2020     |     www.medigraphic.com